Item 7.01 Regulation FD Disclosure.

On December 13, 2019, West Pharmaceutical Services, Inc. (the "Company") issued a press release announcing that its Board of Directors (the "Board") approved a first-quarter 2020 dividend of $0.16 per share. The dividend will be paid on February 5, 2020, to shareholders of record as of January 22, 2020. The Company also announced that its Board authorized a share repurchase program for calendar-year 2020, as described in Item 8.01 below.

On December 10, 2019, the Company appointed Charles Witherspoon, Vice President, Treasury, to the role of Vice President and Treasurer, effective immediately. The role of Treasurer was previously held by Bernard J. Birkett, Senior Vice President and Chief Financial Officer. Mr. Birkett will continue to serve as Senior Vice President and Chief Financial Officer of the Company.

On January 15, 2020, the Company will present an overview of its business at the J.P. Morgan Healthcare Conference in San Francisco, California, at 4:30 PM Pacific Time.

The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that section, nor will it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.




Item 8.01 Other Events.

On December 10, 2019, the Company's Board authorized a share repurchase program for calendar-year 2020 authorizing the repurchase of up to 848,000 shares of the Company's common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. The share repurchase program is expected to be completed by December 31, 2020. The Company's previously-authorized share repurchase program will expire on December 31, 2019.

Item 9.01 Financial Statements and Exhibits.



(d)     Exhibit No. Description
         99.1       West Pharmaceutical Services, Inc. Press Release, dated
                    December 13, 2019.
         104        The cover page from the Company's Current Report on Form 8-K,
                    dated December 10, 2019, formatted in Inline XBRL.





                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses